1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Spontaneous Reporting
  • 1.2.3 Intensified ADR Reporting
  • 1.2.4 Targeted Spontaneous Reporting
  • 1.2.5 Cohort Event Monitoring
  • 1.2.6 EHR Mining
• 1.3 Market by Application
  • 1.3.1 Global Pharmacovigilance (PV) Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Research Organizations
  • 1.3.4 Industrial
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmacovigilance (PV) Market Perspective (2015-2026)
• 2.2 Global Pharmacovigilance (PV) Growth Trends by Regions
  • 2.2.1 Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmacovigilance (PV) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmacovigilance (PV) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmacovigilance (PV) Players by Market Size
  • 3.1.1 Global Top Pharmacovigilance (PV) Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmacovigilance (PV) Revenue Market Share by Players (2015-2020)
• 3.2 Global Pharmacovigilance (PV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Pharmacovigilance (PV) Revenue
• 3.4 Global Pharmacovigilance (PV) Market Concentration Ratio
  • 3.4.1 Global Pharmacovigilance (PV) Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Revenue in 2019
• 3.5 Key Players Pharmacovigilance (PV) Area Served
• 3.6 Key Players Pharmacovigilance (PV) Product Solution and Service
• 3.7 Date of Enter into Pharmacovigilance (PV) Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance (PV) Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmacovigilance (PV) Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmacovigilance (PV) Forecasted Market Size by Type (2021-2026)

5 Pharmacovigilance (PV) Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmacovigilance (PV) Historic Market Size by Application (2015-2020)
• 5.2 Global Pharmacovigilance (PV) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmacovigilance (PV) Market Size (2015-2026)
• 6.2 North America Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 6.3 North America Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 6.4 North America Pharmacovigilance (PV) Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Pharmacovigilance (PV) Market Size (2015-2026)
• 7.2 Europe Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 7.3 Europe Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 7.4 Europe Pharmacovigilance (PV) Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Pharmacovigilance (PV) Market Size (2015-2026)
• 8.2 China Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 8.3 China Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 8.4 China Pharmacovigilance (PV) Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Pharmacovigilance (PV) Market Size (2015-2026)
• 9.2 Japan Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 9.3 Japan Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 9.4 Japan Pharmacovigilance (PV) Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Pharmacovigilance (PV) Market Size (2015-2026)
• 10.2 Southeast Asia Pharmacovigilance (PV) Market Size by Type (2015-2020)
• 10.3 Southeast Asia Pharmacovigilance (PV) Market Size by Application (2015-2020)
• 10.4 Southeast Asia Pharmacovigilance (PV) Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Accenture
  • 11.1.1 Accenture Company Details
  • 11.1.2 Accenture Business Overview
  • 11.1.3 Accenture Pharmacovigilance (PV) Introduction
  • 11.1.4 Accenture Revenue in Pharmacovigilance (PV) Business (2015-2020))
  • 11.1.5 Accenture Recent Development
• 11.2 Clinquest Group B.V.
  • 11.2.1 Clinquest Group B.V. Company Details
  • 11.2.2 Clinquest Group B.V. Business Overview
  • 11.2.3 Clinquest Group B.V. Pharmacovigilance (PV) Introduction
  • 11.2.4 Clinquest Group B.V. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.2.5 Clinquest Group B.V. Recent Development
• 11.3 Cognizant
  • 11.3.1 Cognizant Company Details
  • 11.3.2 Cognizant Business Overview
  • 11.3.3 Cognizant Pharmacovigilance (PV) Introduction
  • 11.3.4 Cognizant Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.3.5 Cognizant Recent Development
• 11.4 Laboratory Corporation of America Holdings
  • 11.4.1 Laboratory Corporation of America Holdings Company Details
  • 11.4.2 Laboratory Corporation of America Holdings Business Overview
  • 11.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Introduction
  • 11.4.4 Laboratory Corporation of America Holdings Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.4.5 Laboratory Corporation of America Holdings Recent Development
• 11.5 IBM Corporation
  • 11.5.1 IBM Corporation Company Details
  • 11.5.2 IBM Corporation Business Overview
  • 11.5.3 IBM Corporation Pharmacovigilance (PV) Introduction
  • 11.5.4 IBM Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.5.5 IBM Corporation Recent Development
• 11.6 ArisGlobal
  • 11.6.1 ArisGlobal Company Details
  • 11.6.2 ArisGlobal Business Overview
  • 11.6.3 ArisGlobal Pharmacovigilance (PV) Introduction
  • 11.6.4 ArisGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.6.5 ArisGlobal Recent Development
• 11.7 ICON plc.
  • 11.7.1 ICON plc. Company Details
  • 11.7.2 ICON plc. Business Overview
  • 11.7.3 ICON plc. Pharmacovigilance (PV) Introduction
  • 11.7.4 ICON plc. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.7.5 ICON plc. Recent Development
• 11.8 Capgemini
  • 11.8.1 Capgemini Company Details
  • 11.8.2 Capgemini Business Overview
  • 11.8.3 Capgemini Pharmacovigilance (PV) Introduction
  • 11.8.4 Capgemini Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.8.5 Capgemini Recent Development
• 11.9 ITClinical
  • 11.9.1 ITClinical Company Details
  • 11.9.2 ITClinical Business Overview
  • 11.9.3 ITClinical Pharmacovigilance (PV) Introduction
  • 11.9.4 ITClinical Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.9.5 ITClinical Recent Development
• 11.10 iMEDGlobal
  • 11.10.1 iMEDGlobal Company Details
  • 11.10.2 iMEDGlobal Business Overview
  • 11.10.3 iMEDGlobal Pharmacovigilance (PV) Introduction
  • 11.10.4 iMEDGlobal Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 11.10.5 iMEDGlobal Recent Development
• 11.11 Foresight Group International AG
  • 10.11.1 Foresight Group International AG Company Details
  • 10.11.2 Foresight Group International AG Business Overview
  • 10.11.3 Foresight Group International AG Pharmacovigilance (PV) Introduction
  • 10.11.4 Foresight Group International AG Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.11.5 Foresight Group International AG Recent Development
• 11.12 TAKE Solutions Ltd.
  • 10.12.1 TAKE Solutions Ltd. Company Details
  • 10.12.2 TAKE Solutions Ltd. Business Overview
  • 10.12.3 TAKE Solutions Ltd. Pharmacovigilance (PV) Introduction
  • 10.12.4 TAKE Solutions Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.12.5 TAKE Solutions Ltd. Recent Development
• 11.13 PAREXEL International Corporation
  • 10.13.1 PAREXEL International Corporation Company Details
  • 10.13.2 PAREXEL International Corporation Business Overview
  • 10.13.3 PAREXEL International Corporation Pharmacovigilance (PV) Introduction
  • 10.13.4 PAREXEL International Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.13.5 PAREXEL International Corporation Recent Development
• 11.14 BioClinica
  • 10.14.1 BioClinica Company Details
  • 10.14.2 BioClinica Business Overview
  • 10.14.3 BioClinica Pharmacovigilance (PV) Introduction
  • 10.14.4 BioClinica Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.14.5 BioClinica Recent Development
• 11.15 Wipro Ltd.
  • 10.15.1 Wipro Ltd. Company Details
  • 10.15.2 Wipro Ltd. Business Overview
  • 10.15.3 Wipro Ltd. Pharmacovigilance (PV) Introduction
  • 10.15.4 Wipro Ltd. Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.15.5 Wipro Ltd. Recent Development
• 11.16 United BioSource Corporation
  • 10.16.1 United BioSource Corporation Company Details
  • 10.16.2 United BioSource Corporation Business Overview
  • 10.16.3 United BioSource Corporation Pharmacovigilance (PV) Introduction
  • 10.16.4 United BioSource Corporation Revenue in Pharmacovigilance (PV) Business (2015-2020)
  • 10.16.5 United BioSource Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Pharmacovigilance (PV) Scope and Market Size
Pharmacovigilance (PV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance (PV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

Market segment by Application, split into
Hospitals
Research Organizations
Industrial

Based on regional and country-level analysis, the Pharmacovigilance (PV) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Pharmacovigilance (PV) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Accenture
Clinquest Group B.V.
Cognizant
Laboratory Corporation of America Holdings
IBM Corporation
ArisGlobal
ICON plc.
Capgemini
ITClinical
iMEDGlobal
Foresight Group International AG
TAKE Solutions Ltd.
PAREXEL International Corporation
BioClinica
Wipro Ltd.
United BioSource Corporation